Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
6
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Enveric Biosciences Inc market cap is $6.04M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Enveric Biosciences Inc 52 week high is $13.25 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Enveric Biosciences Inc 52 week low is $1.17 as of November 22, 2026.
Enveric Biosciences Inc stock price today is $1.35.
Enveric Biosciences Inc stock price yesterday was $1.41.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Enveric Biosciences Inc's P/E ratio is -0.22.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Enveric Biosciences Inc P/B ratio is 1.0551.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Enveric Biosciences Inc 50-day moving average is $1.47.